<html><head></head><body><h1>Didanosine Oral Solution</h1><p class="drug-subtitle"><b>Dosage Form:</b> powder, for oral solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Boxed Warning</li>
<li>Indications and Usage</li>
<li>Dosage and Administration</li>
<li>Dosage Forms and Strengths</li>
<li>Contraindications</li>
<li>Warnings and Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Drug Interactions</li>
<li class="ddc-toggle-hidden">Use In Specific Populations</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Description</li>
<li class="ddc-toggle-hidden">Clinical Pharmacology</li>
<li class="ddc-toggle-hidden">Nonclinical Toxicology</li>
<li class="ddc-toggle-hidden">Clinical Studies</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">Patient Counseling Information</li>
<li class="ddc-toggle-hidden">Medication Guide</li>
</ul><h2>Indications and Usage for Didanosine Oral Solution</h2><h2>Didanosine Oral Solution Dosage and Administration</h2><h3>Recommended Dosage (Adult and Pediatric Patients)</h3><h3>Renal Impairment</h3><h3>Dosage Adjustment</h3><h2>Dosage Forms and Strengths</h2><h2>Contraindications</h2><h3>Allopurinol</h3><h3>Ribavirin</h3><h2>Warnings and Precautions</h2><h3>Pancreatitis</h3><h3>Lactic Acidosis/Severe Hepatomegaly with Steatosis</h3><h3>Hepatic Toxicity</h3><h3>Non-cirrhotic Portal Hypertension</h3><h3>Peripheral Neuropathy</h3><h3>Retinal Changes and Optic Neuritis</h3><h3>Immune Reconstitution Syndrome</h3><h3>Fat Redistribution</h3><h2>Adverse Reactions</h2><ul class="Disc">
<li>Pancreatitis <span class="Italics">[see Boxed Warning, Warnings and Precautions (5.1)]</span></li>
<li>Lactic acidosis/severe hepatomegaly with steatosis <span class="Italics">[see Boxed Warning, Warnings and Precautions (5.2)]</span></li>
<li>Hepatic toxicity <span class="Italics">[see Warnings and Precautions (5.3)]</span></li>
<li>Non-cirrhotic portal hypertension <span class="Italics">[see Warnings and Precautions (5.4)]</span></li>
<li>Peripheral neuropathy <span class="Italics">[see Warnings and Precautions (5.5)]</span></li>
<li>Retinal changes and optic neuritis <span class="Italics">[see Warnings and Precautions (5.6)]</span></li>
</ul><h3>Clinical Trials Experience</h3><h3>Postmarketing Experience</h3><h2>Drug Interactions</h2><h3>Established Drug Interactions</h3><ul class="Disc">
<li>250 mg (adults weighing at least 60 kg with creatinine clearance of at least 60 mL/min)</li>
<li>200 mg (adults weighing less than 60 kg with creatinine clearance of at least 60 mL/min)</li>
</ul><h3>Predicted Drug Interactions</h3><h2>USE IN SPECIFIC POPULATIONS</h2><h3>Pregnancy</h3><h3>Nursing Mothers</h3><h3>Pediatric Use</h3><h3>Geriatric Use</h3><h3>Renal Impairment</h3><h2>Overdosage</h2><h2>Didanosine Oral Solution Description</h2><h2>Didanosine Oral Solution - Clinical Pharmacology</h2><h3>Mechanism of Action</h3><h3>Pharmacokinetics</h3><h3>Microbiology</h3><h2>Nonclinical Toxicology</h2><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><h3>Animal Toxicology and/or Pharmacology</h3><h2>Clinical Studies</h2><h3>Adult Patients</h3><h3>Pediatric Patients</h3><h2>How Supplied/Storage and Handling</h2><h2>Patient Counseling Information</h2><h3>Pancreatitis</h3><h3>Peripheral Neuropathy</h3><h3>Lactic Acidosis and Severe Hepatomegaly with Steatosis</h3><h3>Hepatic Toxicity</h3><h3>Non-cirrhotic Portal Hypertension</h3><h3>Retinal Changes and Optic Neuritis</h3><h3>Fat Redistribution</h3><h3>Concomitant Therapy</h3><h3>General Information</h3><ul class="Disc">
<li><span class="Bold">Do not share needles or other injection equipment.</span></li>
<li><span class="Bold">Do not share personal items that can have blood or body fluids on them, like toothbrushes and razor blades.</span></li>
<li><span class="Bold">Do not have any kind of sex without protection.</span> Always practice safe sex by using a latex or polyurethane condom or other barrier method to lower the chance of sexual contact with semen, vaginal secretions, or blood.</li>
<li><span class="Bold">Do not breastfeed.</span> It is not known if didanosine can be passed to your baby in your breast milk and whether it could harm your baby. Also, mothers with HIV-1 should not breastfeed because HIV-1 can be passed to the baby in breast milk.</li>
</ul><h2>Medication Guide</h2><ul class="Disc">
<li>have had pancreatitis</li>
<li>have advanced HIV (human immunodeficiency virus) infection</li>
<li>have kidney problems</li>
<li>drink alcoholic beverages</li>
<li>take a medicine called ZERIT<span class="Sup">®</span> (stavudine)</li>
</ul><ul class="Disc">
<li>stomach pain</li>
<li>swelling of your stomach</li>
<li>nausea and vomiting</li>
<li>fever</li>
</ul><ul class="Disc">
<li>have liver problems</li>
<li>are pregnant. There have been deaths reported in pregnant women who get lactic acidosis after taking didanosine for oral solution and ZERIT (stavudine).</li>
<li>are overweight</li>
<li>have been treated for a long time with other medicines to treat HIV </li>
</ul><ul class="Disc">
<li>feel weak or tired</li>
<li>have unusual (not normal) muscle pain</li>
<li>have trouble breathing</li>
<li>have stomach pain with nausea and vomiting</li>
<li>feel cold, especially in your arms and legs</li>
<li>feel dizzy or light-headed</li>
<li>have a fast or irregular heartbeat  </li>
</ul><ul class="Disc">
<li>yellowing of your skin or the white of your eyes (jaundice)</li>
<li>dark urine</li>
<li>pain on the right side of your stomach</li>
<li>swelling of your stomach</li>
<li>easy bruising or bleeding</li>
<li>loss of appetite</li>
<li>nausea or vomiting</li>
<li>vomiting blood or dark colored stools (bowel movements)</li>
</ul><ul class="Disc">
<li>ZYLOPRIM<span class="Sup">®</span>, LOPURIN<span class="Sup">®</span>, ALOPRIM<span class="Sup">®</span> (allopurinol)</li>
<li>COPEGUS<span class="Sup">®</span>, REBETOL<span class="Sup">®</span>, RIBASPHERE<span class="Sup">®</span>, RIBAVIRIN<span class="Sup">®</span>, VIRAZOLE<span class="Sup">®</span> (ribavirin) </li>
</ul><ul class="Disc">
<li>have or had kidney problems</li>
<li>have or had liver problems (such as hepatitis)</li>
<li>have or had persistent numbness, tingling, or pain in the hands or feet (neuropathy)</li>
<li>have any other medical conditions</li>
<li>are pregnant or plan to become pregnant. It is not known if didanosine for oral solution will harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking didanosine for oral solution. You and your healthcare provider will decide if you should take didanosine for oral solution while you are pregnant.</li>
</ul><p class="First">Pregnancy Registry: There is a pregnancy registry for women who take antiviral medicines during pregnancy. The purpose of the registry is to collect information about the health of you and your baby. Talk to your doctor about how you can take part in this registry.</p><ul class="Disc">
<li><span class="Bold">are breastfeeding or plan to breastfeed. Do not breastfeed.</span> It is not known if didanosine can be passed to your baby in your breast milk and whether it could harm your baby. Also, mothers with HIV-1 should not breastfeed because HIV-1 can be passed to the baby in the breast milk.</li>
</ul><ul class="Disc">
<li>VIREAD<span class="Sup">®</span> (tenofovir disoproxil fumarate)</li>
<li>DROXIA<span class="Sup">®</span>, HYDREA<span class="Sup">®</span> (hydroxyurea)</li>
<li>RESCRIPTOR<span class="Sup">®</span> (delavirdine mesylate)</li>
<li>CYTOVENE<span class="Sup">®</span>, VALCYTE<span class="Sup">®</span> (ganciclovir)</li>
<li>CRIXIVAN<span class="Sup">®</span> (indinavir)</li>
<li>DOLOPHINE<span class="Sup">®</span> HYDROCHLORIDE, METHADOSE<span class="Sup">®</span> (methadone)</li>
<li>VIRACEPT<span class="Sup">®</span> (nelfinavir)</li>
<li>antacids</li>
<li>antifungal medicines such as NIZORAL<span class="Sup">®</span> (ketoconazole) or SPORANOX<span class="Sup">®</span> (itraconazole)</li>
<li>quinolone antibiotics such as CIPRO<span class="Sup">®</span>, PROQUIN<span class="Sup">®</span> XR (ciprofloxacin)</li>
<li>tetracycline antibiotics such as BRISTACYCLINE<span class="Sup">®</span>, SUMYCIN<span class="Sup">®</span> (tetracycline)</li>
<li>alcoholic beverages</li>
</ul><ul class="Disc">
<li>Take didanosine for oral solution exactly as your healthcare provider tells you to take it.</li>
<li>Your healthcare provider will tell you how much didanosine for oral solution to take and when to take it.</li>
<li>Your healthcare provider may change your dose. Do not change your dose of didanosine for oral solution without talking to your healthcare provider.</li>
<li><span class="Bold">Do not take didanosine for oral solution with food.</span> Take didanosine for oral solution on an empty stomach at least 30 minutes before or 2 hours after you eat.</li>
<li>Try not to miss a dose, but if you do, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule.</li>
<li><span class="Bold">Some medicines should not be taken at the same time of day that you take didanosine for oral solution.</span> Check with your healthcare provider.</li>
<li>If your kidneys are not working well, your healthcare provider will need to do regular blood and urine tests to check how they are working while you take didanosine for oral solution. Your healthcare provider may also lower your dosage of didanosine for oral solution if your kidneys are not working well.</li>
<li><span class="Bold">If you take too much didanosine for oral solution,</span> contact a poison control center or emergency room right away.</li>
</ul><ul class="Disc">
<li><span class="Bold">Alcohol.</span> Do not drink alcohol while you take didanosine for oral solution. Alcohol may increase your risk of getting pain and swelling of your pancreas (pancreatitis) or may damage your liver.</li>
</ul><ul class="Disc">
<li><span class="Bold">Vision changes.</span> You should have regular eye exams while you take didanosine for oral solution.</li>
<li><span class="Bold">Peripheral neuropathy.</span> Symptoms include: numbness, tingling, or pain in your hands or feet. This condition is more likely to happen in people who have had it before, in patients taking medicines that affect the nerves, and in people with advanced HIV disease. A child may not notice these symptoms. Ask your child's healthcare provider for the signs and symptoms of peripheral neuropathy in children.</li>
<li><span class="Bold">Changes in your immune system (immune reconstitution syndrome).</span> Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider if you start having new or worse symptoms of infection after you start taking HIV medicine.</li>
<li><span class="Bold">Changes in body fat (fat redistribution).</span> Changes in body fat have been seen in people who take antiretroviral medicines. These changes may include:</li>
</ul><ul class="Disc">
<li>more fat in or around your </li>
</ul><ul class="Disc">
<li>less fat in your </li>
</ul><ul class="Disc">
<li>diarrhea</li>
<li>stomach pain</li>
<li>nausea</li>
<li>vomiting</li>
<li>headache</li>
<li>rash</li>
</ul><ul class="Disc">
<li>Safely throw away any unused didanosine for oral solution after 30 days.</li>
</ul><ul class="Disc">
<li><span class="Bold">Do not share needles or other injection equipment.</span></li>
<li><span class="Bold">Do not share personal items that can have blood or body fluids on them, like toothbrushes and razor blades.</span></li>
<li><span class="Bold">Do not have any kind of sex without protection.</span> Always practice safe sex by using a latex or polyurethane condom or other barrier method to lower the chance of sexual contact with semen, vaginal secretions, or blood.<br/></li>
</ul><h2>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg/mL (2 g Bottle)</h2><h2>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg/mL Carton (2 g Bottle)</h2><h2>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg/mL (4 g Bottle)</h2><h2>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg/mL Carton (4 g Bottle)</h2><h2>More about didanosine</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Didanosine &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Didanosine &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Didanosine &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Didanosine Tablet, for suspension &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>HIV Infection</li>
<li>Nonoccupational Exposure</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>